2023
American College of Radiology initiatives on prostate magnetic resonance imaging quality
Purysko A, Tempany C, Macura K, Turkbey B, Rosenkrantz A, Gupta R, Attridge L, Hernandez D, Garcia-Tomkins K, Bhargavan-Chatfield M, Weinreb J, Larson D. American College of Radiology initiatives on prostate magnetic resonance imaging quality. European Journal Of Radiology 2023, 165: 110937. PMID: 37352683, PMCID: PMC10461171, DOI: 10.1016/j.ejrad.2023.110937.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingProstate magnetic resonance imagingAmerican CollegePatient careACR Appropriateness CriteriaProstate Imaging ReportingQuality Improvement CollaborativeHigh-quality patient careMRI qualityUrogenital RadiologyCenter designationAppropriateness CriteriaPatient outcomesProstate cancerClinical practiceImaging ReportingResonance imagingEuropean SocietyCareControl programsInternational panelMagnetic resonance imaging qualityRadiologyQuality control programPatients
2018
MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.
Sheridan AD, Nath SK, Aneja S, Syed JS, Pahade J, Mathur M, Sprenkle P, Weinreb JC, Spektor M. MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI. American Journal Of Roentgenology 2018, 210: w218-w225. PMID: 29489409, DOI: 10.2214/ajr.17.18680.Peer-Reviewed Original ResearchConceptsPI-RADS 5 lesionsBenign pathologic resultsLower prostate-specific antigen densitySignificant prostate cancerProstate-specific antigen densityBenign prostatic hyperplasia nodulesMRI-ultrasound fusionProstate Imaging ReportingCategory 5 lesionsPathologic resultsProstate cancerClinical featuresBenign diseaseAntigen densityImaging ReportingGleason 6 diseasePI-RADS version 2High-risk lesionsMultivariate logistic regressionRoutine clinical interpretationMultiparametric prostate MRIInflammatory changesNormal anatomic structuresBiopsy resultsTargeted biopsiesIs PI-RADS 3/total lesion ratio associated with clinically-significant prostate cancer in patients with equivocal-risk lesions on multi-parametric MRI?
Ghabili K, Swallow M, Suarez-Sarmiento A, Syed J, Leapman M, Weinreb J, Sprenkle P. Is PI-RADS 3/total lesion ratio associated with clinically-significant prostate cancer in patients with equivocal-risk lesions on multi-parametric MRI? Journal Of Clinical Oncology 2018, 36: 149-149. DOI: 10.1200/jco.2018.36.6_suppl.149.Peer-Reviewed Original ResearchSmaller prostate volumeMulti-parametric MRISignificant prostate cancerProstate volumeProstate cancerROI ratioPSA densityGrade groupPrediction of csPCaRisk of csPCaData System (BI-RADS) category 3Prostate Imaging ReportingMpMRI findingsBiopsy databasePrior diagnosisTargeted biopsiesFusion biopsyPositive coresCsPCaUnnecessary biopsiesBiopsyMultivariate analysisPatientsImaging ReportingLesions